Injury Prevention is an international peer reviewed journal that offers the best in science, policy, and public health practice to reduce the burden of injury in all age groups around the world. The journal publishes original research, opinion, debate and special features on the prevention of unintentional, occupational and intentional (violence-related) injuries.

Authors may wish to refer to an editorial on the manuscript selection process for Injury Prevention: “Editorial licence: what gets published and why”.

Editorial policy

Injury Prevention adheres to the highest standards concerning its editorial policies on publication ethics, scientific misconduct, consent and peer review criteria. To view all BMJ Journal policies please refer to the BMJ Author Hub policies page. More information on copyright and authors’ rights.

As a matter of conformity with BMJ policy (BMJ. 2001; 322(7298):1320-1321) this Journal does not permit the use of the word ‘accident’ except where it appears in a formal title e.g. Child Accident Prevention Trust.

Plan S compliance

Injury Prevention is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.

Copyright and authors’ rights

Articles are published under an exclusive licence or non-exclusive licence for UK Crown employees or where BMJ has agreed CC BY applies. For US Federal Government officers or employees acting as part of their official duties, the terms are as stated in accordance with our licence terms. Authors or their employers retain copyright. Open access articles can be reused under the terms of the relevant Creative Commons licence to facilitate reuse of the content; please refer to the Injury Prevention Author Licence for the applicable Creative Commons licences”.

When publishing in Injury Prevention, authors choose between three licence types – exclusive licence granted to BMJ, CC-BY-NC and CC-BY (Creative Commons open access licences require payment of an article processing charge). As an author you may wish to post your article in an institutional or subject repository, or on a scientific social sharing network. You may also link your published article to your preprint (if applicable). What you can do with your article, without seeking permission, depends on the licence you have chosen and the version of your article. Please refer to the BMJ author self archiving and permissions policies page for more information.


Preprints foster openness, accessibility and collaboration by allowing authors to make their findings immediately available to the research community and receive feedback on an article before it is submitted to a journal for formal publication.

BMJ fully supports and encourages the archiving of preprints in any recognised, not-for-profit server such as medRxiv. BMJ does not consider the posting of an article in a dedicated preprint repository to be prior publication.

Preprints are reports of work that have not been peer-reviewed; Preprints should therefore not be used to guide clinical practice, health-related behaviour or health policy. For more information, please refer to our Preprint policy page.

Data sharing

Injury Prevention adheres to BMJ’s Tier 2 data policy. We strongly encourage that data generated by your research that supports your article be made available as soon as possible, wherever legally and ethically possible. We also require data from clinical trials to be made available upon reasonable request. To adhere to ICMJE guidelines, we require that a data sharing plan must be included with trial registration for clinical trials that begin enrolling participants on or after 1st January 2019. Changes to the plan must be noted in the Data Availability Statement and updated in the registry record. All research articles must contain a Data Availability Statement. For more information and FAQs, please see BMJ’s full Data Sharing Policy page.

Patient and public partnership

BMJ encourages active patient and public involvement in clinical research as part of its patient and public partnership strategy. To support co-production of research we request that authors provide a Patient and Public Involvement statement in the methods section of their papers, under the subheading ‘Patient and public involvement’.

We appreciate that patient and public involvement is relatively new and may not be feasible or appropriate for all papers. We therefore continue to consider papers where patients were not involved.

The Patient and Public Involvement statement should provide a brief response to the following questions, tailored as appropriate for the study design reported (please find example statements here:

  • At what stage in the research process were patients/the public first involved in the research and how?
  • How were the research question(s) and outcome measures developed and informed by their priorities, experience, and preferences?
  • How were patients/the public involved in the design of this study?
  • How were they involved in the recruitment to and conduct of the study?
  • Were they asked to assess the burden of the intervention and time required to participate in the research?
  • How were (or will) they be involved in your plans to disseminate the study results to participants and relevant wider patient communities (e.g. by choosing what information/results to share, when, and in what format)?

If patients were not involved please state this.

In addition to considering the points above we advise authors to look at guidance for best reporting of patient and public involvement as set out in the GRIPP2 reporting checklist.

If the Patient and Public Involvement statement  is missing in the submitted manuscript we will request that authors provide it.


Injury Prevention mandates ORCID iDs for the submitting author at the time of article submission; co-authors and reviewers are strongly encouraged to also connect their ScholarOne accounts to ORCID. We strongly believe that the increased use and integration of ORCID iDs will be beneficial for the whole research community.

Please find more information about ORCID and BMJ’s policy on our Author Hub.

Data files

Multimedia files: Authors are encouraged to submit multimedia files, including videos. Further details can be found in our Manuscript preparation guidelines.

Sharing of data collection tools: If you have used a non-proprietary data collection tool in your research or you developed a survey, checklist, or assessment form, please consider uploading and sharing that tool through the SAVIR Instrument Library on Shared data collection tools allow investigators in our field to work more efficiently and to generate directly comparable research results.

Article transfer service

BMJ is committed to ensuring that all good quality research is published. Our article transfer service helps authors find the best journal for their research while providing an easy and smooth publication process. If authors agree to transfer their manuscript, all versions, supplementary files and peer reviewer comments are automatically transferred; there is no need to resubmit or reformat.

Authors who submit to the Injury Prevention and are rejected will be offered the option of transferring to another BMJ Journal, such as BMJ Open.

Please note that the article transfer service does not guarantee acceptance but you should receive a quicker initial decision on your manuscript.

Contact the Product Owner of BMJ’s Article Transfer Service for more information or assistance.

Article processing charges

During submission, authors can choose to have their article published open access for 2,300 GBP (exclusive of VAT for UK and EU authors). Publishing open access has multiple benefits including wider reach, faster impact and increased citation and usage. There are no submission, page or colour figure charges.

Find out if you are eligible for institutional funding

A number of institutions have open access agreements with BMJ which can either cover the whole cost of open access publishing for authors at participating institutions or can allow authors to receive a discount off the APC.

Visit BMJ’s open access agreements page to find out whether your institution is a member and what discounts you may be entitled to.
For more information on publishing open access with BMJ visit our Author Hub.

Rapid responses

A rapid response is a moderated but not peer reviewed online response to a published article in Injury Prevention; it will not receive a DOI and will not be indexed. Find out more about responses and how to submit a response.

Submission guidelines

Please review the below article type specifications including the required article lengths, illustrations, table limits and reference counts. The word count excludes the title page, abstract, tables, acknowledgements, contributions and references. Manuscripts should be as succinct as possible.

For further support when making your submission please refer to the resources available on the BMJ Author Hub. Here you will find information on writing and formatting your research through to the peer review process and promoting your paper. You may also wish to use the language editing and translation services provided by BMJ Author Services.

Original research

Please note that we require registration of clinical trials and reporting of randomized clinical trials according to the CONSORT guidelines. We also ask that authors follow the STROBE guidelines when reporting observational studies.

Although not required for publication in Injury Prevention, authors are encouraged to review similar published guidelines for the reporting of systematic reviews, meta-analyses, and assessments of diagnostic test. Templates for CONSORT, STROBE and other reporting guidelines are available through the Equator Network.

Please include a key messages section with 2-3 bullet points under two headings: “What is already known on this subject” and “What this study adds”, summarising the context and contributions of your paper.

Following the lead of The BMJ and its patient partnership strategy, Injury Prevention is encouraging active patient involvement in setting the research agenda. As such, we require authors of Original Research Articles to add a Patient and Public Involvement statement in the Methods section. Please see more details above.

Word count: up to 3000 words
Structured Abstract: up to 250 words
Tables/Illustrations: up to 6
References: up to 40

Brief report

Brief reports are intended to highlight interesting findings that do not warrant the space required of an original article. They differ from Correspondence in that they present data or findings that stand on their own, rather than referring to a work already published.

Please include a key messages section with 2-3 bullet points under two headings: “What is already known on this subject” and “What this study adds”, summarising the context and contributions of your paper.

Length: up to 1500 words
Abstract: up to 150 words
Tables/Illustrations: up to 4
References: up to 20


New methodological contributions are important to this field, as are studies or appraisals of existing methodological approaches. Papers with this focus are reviewed in the same manner as Original Articles. Detailed items (large tables or graphs) can be included but may be published as supplementary files.

Word count: up to 3000 words
Structured Abstract: up to 250 words
Tables/Illustrations: up to 6
References: up to 40

Systematic review

Systematic reviews and meta-analyses are welcomed. Detailed items (large tables or graphs) can be included but may be published as supplementary files.

Please include a key messages section with 2-3 bullet points under two headings: “What is already known on this subject” and “What this study adds”, summarising the context and contributions of your paper.

Word count: up to 4000 words
Structured Abstract: up to 250 words
Tables/Illustrations: up to 6
References: up to 60

State of the art review

These are intended to be comprehensive, evidence-based summaries of topics at the leading edge of injury prevention research. They are usually commissioned, but unsolicited reviews are welcomed.

The review should follow this structure:
Introduction: An outline of why this topic is important.
Critical issues: The specific cutting edge, topical, or problematic elements of the topic that make this a ‘hot’ topic. Each issue should be stated and the evidence (for/against) each one included.
Gaps in the literature: Indicating where more research needs to be done.
Recommendations: Advice for practitioners, based on the current available evidence summarised in the article.
Future directions: Advice for researchers, outlining the next steps to further advance the field.

Word count: up to 3500 words
Tables/Illustrations: up to 6
References: up to 50


The journal publishes protocols for studies in the field that have been proposed or funded and that may or may not yet be recruiting subjects. Study protocols will be considered for 1) controlled trials; 2) systematic reviews; and 3) controlled observational studies.

Submitted protocols must conform to the appropriate reporting guidelines. Templates for CONSORT, STROBE and other reporting guidelines are available through the Equator Network. All clinical trials must be prospectively registered. Any study protocol currently enrolling subjects must have evidence of appropriate ethical review.

Protocols that have secured funding from an agency following scientific peer review will be screened by an editorial team for originality, suitability of design and general interest to the readership. Please upload completed peer review comments for inspection. Protocols passing this initial screen will be published without additional review. Post-publication commentary is available on the website and may be useful to authors in revising or updating protocols.

If the protocol has not been funded on the basis of peer review, the protocol will be screened and may be sent for formal peer review by the journal with the option of returning the manuscript to the authors for revision.

Word count: unlimited

Student submission

The journal considers papers authored by trainees in any discipline. These will undergo peer review but may be offered additional opportunities for revision and resubmission if required. These submissions are typically invited by one of our affiliated societies or commissioned by a conference organiser. The sponsoring agency should be identified in the covering letter. We regret that we cannot consider unsolicited submissions in this category.

Please include a key messages section with 2-3 bullet points under two headings: “What is already known on this subject” and “What this study adds”, summarising the context and contributions of your paper.

Word count: up to 2500 words
Abstract: up to 250 words
Tables/Illustrations: up to 4
References: up to 30

Special feature

Special features is a category reserved for papers that do not fit neatly in any of the other categories. Authors with what they believe to be such papers are encouraged to communicate with the Editor before submission.

As a rule, special features will be about 3000 words. A special feature need not follow the customary structure of a research or review paper.

Media review

Books, video, software and other media of interest to the injury prevention community are occasionally reviewed. Authors wishing to contribute in this category should discuss their ideas with the Editor in advance of submission.

Word count: up to 900 words
Tables/Illustrations: up to 2
References: up to 8


The BMJ Publishing Group journals are willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of:

  • The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
  • The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
  • The BMJPG itself may have proposals for supplements where sponsorship may be necessary.
  • A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.

In all cases, it is vital that the journal’s integrity, independence and academic reputation is not compromised in any way.

For further information on criteria that must be fulfilled, download the supplements guidelines.

When contacting us regarding a potential supplement, please include as much of the information below as possible.

  • Journal in which you would like the supplement published
  • Title of supplement and/or meeting on which it is based
  • Date of meeting on which it is based
  • Proposed table of contents with provisional article titles and proposed authors
  • An indication of whether authors have agreed to participate
  • Sponsor information including any relevant deadlines
  • An indication of the expected length of each paper Guest Editor proposals if appropriate